Alphatec Holdings Inc
NASDAQ:ATEC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.98
16.78
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Alphatec Holdings Inc
Alphatec Holdings Inc
Cash & Cash Equivalents
Alphatec Holdings Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Alphatec Holdings Inc
NASDAQ:ATEC
|
Cash & Cash Equivalents
$81m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash & Cash Equivalents
$1.7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
26%
|
CAGR 10-Years
-1%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash & Cash Equivalents
$2.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
55%
|
CAGR 10-Years
26%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash & Cash Equivalents
$3.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash & Cash Equivalents
$7.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash & Cash Equivalents
$2.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
20%
|
CAGR 10-Years
17%
|
|
Alphatec Holdings Inc
Glance View
Alphatec Holdings Inc., often recognized under its brand ATEC, is a dynamic entity within the spinal solutions market. The company, based in Carlsbad, California, has passionately committed to transforming spinal surgeries, focusing on surgical innovation to solve the most persistent challenges faced by surgeons. ATEC started with a vision to shake up the staid, conventional spine surgery landscape by leveraging technology to improve surgical techniques and patient outcomes. This commitment to innovation is evident in its robust pipeline of products designed for various spinal disorders and conditions. By investing heavily in research and development, ATEC consistently brings to market cutting-edge solutions that align with its goal of revolutionizing surgical spine treatment. Its approach to problem-solving sets it apart: rather than an off-the-shelf attitude, ATEC works closely with surgeons to create tailored solutions that meet the individualized needs of their patients. The financial engine of Alphatec revolves around the commercial reach of its proprietary spinal hardware and biologics portfolio. The company taps into a growing demand for advanced spinal surgery technologies, channeling its expansive product line through its sales team and collaboration with distribution partners. Revenues primarily stem from product sales, where the integration of new technologies such as its AlphaInformatiX platform, an integrated software suite, enhances the surgical experience through real-time analytics and visualization, creating additional value for healthcare providers. By focusing on high-margin, innovative products, while continually expanding its distribution networks and scaling its operations to meet increasing demand, ATEC positions itself as an essential player with the potential for sustainable revenue growth in the competitive spine surgery market.
See Also
What is Alphatec Holdings Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
81m
USD
Based on the financial report for Sep 30, 2024, Alphatec Holdings Inc's Cash & Cash Equivalents amounts to 81m USD.
What is Alphatec Holdings Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
15%
Over the last year, the Cash & Cash Equivalents growth was -34%. The average annual Cash & Cash Equivalents growth rates for Alphatec Holdings Inc have been -29% over the past three years , 7% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet